A practical rundown of insurance coverage for Wegovy when it is prescribed for weight loss, aimed at people sorting out costs.
Recap by typeshit. Full story at Universitat de Barcelona.
New generics and steady prices drove the jump in value despite fewer units sold, with Eli Lilly's tirzepatide featured in the breakdown.
Medicare is rolling out a GLP-1 program priced at $50 a month. KTLA walks through who is eligible and who is left out.
Novo has lowered what it charges for Wegovy in China. Details on the size of the cut are in the full report.
The new Medicare program could cut GLP-1 costs by thousands for people on it, though many beneficiaries will not meet the eligibility rules.
MD Aman Mehta gave the timeline as Brazil revenue rose 38%. In India, Torrent holds a 32% share of generic semaglutide after a two-month supply gap.
Mariem Dekhili's weekly overview covers GLP-1 eye warnings alongside the Pope's France visit and Russia in the Sahel.
Loading…